Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Venous ulcer Stories

2009-11-02 09:30:00

SAN DIEGO, Nov. 2 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans to submit a 510(k) premarket notification with the U.S. Food and Drug Administration (FDA) seeking marketing clearance of its ExcellagenXL(TM) product candidate. ExcellagenXL is an advanced wound care management medical device, which is a customized collagen-based topical gel designed for use by physicians in patients with topical wounds, which include diabetic ulcers as well as...

2009-10-23 12:17:00

ADDISON, Texas, Oct. 23 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that Gregory Bohn, M.D., FACS, Medical Director, Trinity Wound Care and Hyperbaric Medicine, Bettendorf, Iowa, has presented nine clinical posters at the 24th Annual "Clinical Symposium on Advances in Skin and Wound Care" being held in San Antonio, Texas. Highlights of the clinical experience presented by Dr. Bohn's poster presentations include: A stagnated traumatic wound that was...

2009-10-22 13:21:00

LONDON, October 22 /PRNewswire/ -- Systagenix Wound Management, has unveiled SILVERCEL* Non-Adherent dressing a powerful new antimicrobial silver dressing with a unique non -adherent layer that controls infection and minimises trauma with each dressing change. SILVERCEL* Non- Adherent dressing can be easily removed in one piece without adhering to the wound bed. Suitable for infected, chronic and acute wounds, SILVERCEL* Non -Adherent dressing has been uniquely designed to leave...

2009-10-22 07:30:00

ADDISON, Texas, Oct. 22 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that a poster highlighting the benefits of using Altrazeal(TM) in the home care market segment will be among the Altrazeal(TM) posters being presented at the 24th Annual "Clinical Symposium on Advances in Skin and Wound Care" in San Antonio, Texas from October 22-25. The poster, presented by Bobbie Spitz, R.N., M.S.N., CWS, from Aurora Home Health visiting nurse association of...

2009-10-21 09:54:00

ADDISON, Texas, Oct. 21 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that there will be 16 poster presentations featuring clinical and pharmacoeconomic results at the 24th Annual "Clinical Symposium on Advances in Skin and Wound Care" to be held in San Antonio, Texas from October 22-25. The posters are being presented by seven different clinical groups and highlight the benefits of using Altrazeal(TM) in numerous wound types including, diabetic foot...

2009-10-16 07:30:00

FORT WORTH, Texas, Oct. 16 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today that its subsidiary Wound Care Innovations, LLC will exhibit at the 24th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing, which opens on October 22 in San Antonio. Dr. Jane Fore MD, FAPWCA, FACCWS, medical director of the Tri-State Wound...

2009-10-13 13:50:12

The UK National Health Service could save millions of pounds a year by routinely using inexpensive dressings to treat venous leg ulcers, after a study published in the October issue of BJS showed that they are just as effective as expensive silver dressings in the majority of cases. Researchers, led by Professor Jonathan Michaels from the Sheffield Vascular Institute and Professor Bruce Campbell from the Royal Devon and Exeter Hospital, studied 213 leg ulcer patients who received either...

2009-09-01 06:30:00

MOUNTAIN VIEW, Calif., Sept. 1 /PRNewswire/ -- The maturity of the U.S. compression therapy market is necessitating the introduction of advanced technologies to break the growth plateau. Manufacturers are using the concept of evidence-based medicine to educate physicians and encourage the adoption of new technologies. Growing health awareness among consumers has spurred the demand for early diagnosis and preventive approaches. This, coupled with the increasing incidence of obesity and...

2009-06-16 16:43:00

Multi-Center, Randomized Trial to Test Unique Delivery System Using Living Cells to Enhance Wound Healing Marks Milestone for Fort Worth, Texas-based Specialty Biopharmaceutical Company FORT WORTH, Texas, June 16 /PRNewswire/ -- HEALTHPOINT, Ltd. today announced that it has enrolled the first of a planned 235 subjects into a Phase II dose response study investigating an experimental, cell-based wound therapy ---HP802-247---intended for the treatment of venous leg ulcers. HP802-247 is a...

2009-04-07 09:00:00

ROCKVILLE, Md., April 7 /PRNewswire/ -- Glycotex, Inc. today announced the completion of a scheduled interim analysis in a Phase II study evaluating the effect of investigational GLYC-101 gel on complete wound closure and cosmetic outcomes in cosmetic surgery patients undergoing carbon dioxide laser skin resurfacing on the lower eyelid area. The interim analysis was conducted after 26 subjects completed the study. The comparison of each active arm to placebo with respect to the primary...